What is Insulet's common stock, shares issued (in shares)?

Insulet (PODD) reported common stock, shares issued (in shares) of $70.71M in Q1 2026.

How has Insulet's common stock, shares issued (in shares) changed year-over-year?

Insulet's common stock, shares issued (in shares) increased by 0.5% year-over-year, from $70.36M to $70.71M.

What is the long-term trend for Insulet's common stock, shares issued (in shares)?

Over 5 years (2020 to 2025), Insulet's common stock, shares issued (in shares) has grown at a 1.3% compound annual growth rate (CAGR), from $66.02M to $70.59M.

Insulet PODD Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

MedtronicMDT

——

AptarGroupATR

——

West Pharmaceutical ServicesWST

——

AbbottABT

——

Halozyme TherapeuticsHALO

——

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$761.7M+33.9%

Gross profit$529.0M+29.3%

Operating income$122.1M+37.5%

Net income$91.1M+157%

EPS (diluted)$1.30+160%

Balance sheet

See full

Cash & equivalents$480.4M-62.6%

Total debt$969.7M-45.5%

Total equity$1.3B-2.1%

Total assets$3.0B-15.1%

Cash flow

See full

Operating cash flow$113.8M+78.4%

CapEx$24.3M+97.6%

Free cash flow$89.5M+73.8%

Valuation

See full

Market cap$10.1B-19.9%

Enterprise value$10.59B-19.4%

P/E33.3×+2.0×

P/S3.5×-2.3×

Profitability

See full

Gross margin71%+0.6pp

Operating margin17.5%+2.0pp

Net margin10.4%-7.9pp

FCF margin14.3%+1.1pp

Returns & leverage

See full

Return on equity23%-14.9pp

Debt / equity0.7×-0.6×

Current ratio2.5×-2.0×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Insulet’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insulet's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insulet's common stock, shares issued (in shares)?: Insulet (PODD) reported common stock, shares issued (in shares) of $70.71M in Q1 2026.
How has Insulet's common stock, shares issued (in shares) changed year-over-year?: Insulet's common stock, shares issued (in shares) increased by 0.5% year-over-year, from $70.36M to $70.71M.
What is the long-term trend for Insulet's common stock, shares issued (in shares)?: Over 5 years (2020 to 2025), Insulet's common stock, shares issued (in shares) has grown at a 1.3% compound annual growth rate (CAGR), from $66.02M to $70.59M.